Investors
- Board of Directors
- Board Meeting
- AGM Notice
- EGM Notice
- Closure Of Trading Window
- Related Party Transactions
- Share Holding Patterns
- Quarterly Results
- Annual Report
- Annual Return
- Secretarial Compliance
- Disclosure U/r 30
- Voting Results
- Newspaper Publications
- Insider Trading Code
- Investors-2
Mail to: companysec@indswift.com[Email id of designated official for the purpose of grievance redressal]
UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 31st MARCH, 2007 |
|||||
|---|---|---|---|---|---|
(RS. IN LACS) |
|||||
PARTICULARS |
Unaudited quarter 31.03.2007 |
Reviewed quater 31.03.2006 |
Unaudited Year Ended 31.03.2007 |
Audited Year End 31.03.2006 |
|
| Income from Operations | 10312.54 |
5534.92 |
38556.60 |
27491.34 |
|
| Others Income | 18.14 |
16.40 |
134.11 |
128.95 |
|
| TOTAL INCOME | 10330.68 |
5551.32 |
38690.71 |
27620.29 |
|
| Total Expenditure | 9076.14 |
4882.67 |
33747.92 |
24186.29 |
|
| Decrease in Stock in trade | -1505.70 |
-287.38 |
-1823.03 |
-516.59 |
|
| Consumption of raw material | 9252.45 |
4376.62 |
30060.47 |
20760.28 |
|
| Cost of Sales | 7746.75 |
4089.24 |
28237.44 |
20243.69 |
|
| Staff Cost | 368.09 |
228.97 |
1372.04 |
1107.36 |
|
| Other expenses | 961.30 |
564.46 |
4138.44 |
2835.24 |
|
| Interest | 499.89 |
306.56 |
1760.64 |
1093.84 |
|
| Depreciation | 95.15 |
42.20 |
304.85 |
146.48 |
|
| PROFIT BEFORE TAX | 659.50 |
319.89 |
2877.30 |
2193.68 |
|
| Provision for Tax(Incl. FBT.) | 83.47 |
41.08 |
355.82 |
214.78 |
|
| Provision for Deferred Tax | 80.60 |
153.15 |
292.40 |
252.29 |
|
| Net Profit | 495.43 |
125.66 |
2229.08 |
1726.61 |
|
| Share Capital | 743.57 |
743.57 |
743.57 |
743.57 |
|
| Reserves excluding | 11933.69 |
||||
| Revaluation Reserves EPS(Basic & Diluted) | 1.33 |
0.34 |
6.00 |
4.64 |
|
| AGGREGATE OF NON-PROMOTERS SHAREHOLDING | |||||
| NUMBER OF SHARES | 23985890 | 24056475 | 223985890 | 24056475 | |
| % OF SHARE HOLDING | 64.51% |
64.70% |
64.51% |
64.70% |
|
Notes:- |
|||||
1. During the quarter under review, the turnover of the company grew by 86.32% and profit before Tax grew by 294.26% compared to same period during previous year. 2..The Company is exclusively in the Pharmaceutical business segment. 3.Inventors complaints for quater: Openning - Nill , Received - 5, Redressed - 5, Closing Balance - Nill. 4.The above results were reviewed by the audit committee and taken on record by Board of Directors of the company by their respective meetings held on 30th April, 2007. |
|||||
For and on Behalf of the Board of Directors |
|||||
| Dated: 28.04.2007 | (Dr. Gopal Munjal) |
||||
| Place: Chandigarh | Chairman |
||||